Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

Egypt

 

Is IDH rethinking its IPO?

Egyptian lab group, Integrated Diagnostics holdings, could be reconsidering the structure of its IPO. IDH sold a 21% stake to an unnamed European investor before Christmas said well-placed sources.
March 11, 2015

Major African investors ready the money

The two largest private equity investors in Africa, Abraaj and the Investment Fund for Health in Africa, are both raising new funds. So how are they progressing and what are their strategies? We investigated at the Africa Healthcare Summit in London.
March 3, 2015

North Africa healthcare gets big boost from global investors

Private equity fund Abraaj, the European Bank for Reconstruction and Development (EBRD), German institutional investor DEG and French group Proparco are set to partner up to improve private healthcare in Egypt and Tunisia via the North Africa Hospital Holdings Group (NAHHG).
March 3, 2015

Diagnostics set to rocket in Africa

The lab and imaging services are set to soar across Africa, according to delegates and speakers at Africa Healthcare Summit 2015. New chains are growing fast in most countries, sometimes backed by major medtech players. And there is a huge international trade in esoteric tests. Meanwhile GE Healthcare has all but doubled sales in three years. We look at who is who and where.
March 3, 2015

From Around The World

Our weekly roundup of healthcare news from across the developing world. This week, we have stories from Kenya, China and Israel.
January 27, 2015

Saudi hospital group may sell 30% stake

Dr. Soliman Fakeeh Hospital (DSFH), the owner of one of Saudi Arabia’s largest private hospitals may sell a 30% stake through an initial public offering (IPO).
January 27, 2015

IDH announces London IPO in February

Egyptian lab group IDH (Integrated Diagnostics Holdings) is using Egypt’s more settled political situation to cash in on mega-profits. The group expects a market capitalisation of $600m at IPO and could float up to 45% of the share capital. Before tax profits came to $21m, a margin of 25%, in the financial year ending 30 Sep 2014, on sales of $87m, up 27.5%. EBITDA margin stands at 42%.
January 20, 2015

Interview: Ahmed Badreldin, Partner, The Abraaj Group

No other private equity house can match Abraaj’s experience of investing in healthcare services in the developing world. A lead investor in Turkish hospital group Acibadem, which was then sold to IHH, the international hospital chain, Abraaj has rolled out a lab buy and build in Egypt, Africa and the Middle East, has recently started a similar play building a Pan-North African chain of hospitals and has also invested in half a dozen hospital and outpatient clinics across sub-Saharan Africa. Ahmed will be speaking at Healthcare Europa 2015 on April 28 in London.
July 24, 2014
Older posts
Newer posts

Our Services

Company

Resources

Log in
Register
Log in
Register

Our Services

Company

Resources

Find Us